Trastuzumab + fluoropyrimidine maintenance in the frontline setting for non-progressing advanced HER-2 positive gastroesophageal adenocarcinoma.
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Ahmed Abdelhakeem, Jane Elizabeth Rogers, Xuemei Wang, Irene Thomas, Mariela A. Blum-Murphy, Allison Trail, Meina Zhao, Jaffer A. Ajani
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3005195564